RBM is an important part of a pro-active clinical trial management monitoring approach, which aims to identify, assess, control, communicate and review the risks associated with the clinical trial during its life cycle to protect the trial subject’s rights, well-being, integrity, and safety and the assurance of the quality of data and the trial credibility.
TULA solution helps organizations focus on key clinical trial study parameters. Our solution comes with predictive analytical capabilities, statistical modeling, and machine learning techniques to provide early insights into trial risks enabling more precise decision making in clinical monitoring.